Alembic Pharma gets USFDA nod for Fulvestrant injection, 250 mg/5 mL per single-dose syringe
Fulvestrant injection is an estrogen receptor antagonist indicated for the treatment of breast cancer
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
breast cancer
Israeli scientists find promising target for breast cancer and other cancer therapeutics
Our perception of the specific multistep molecular mechanistic process which regulates cancer initiation and progression found in…
Sanofi partners with BIG, EORTC, AFT to study amcenestrant for ER+ breast cancer treatment
Amcenestrant is an oral SERD that antagonises and degrades the estrogen receptor (ER), resulting in inhibition of the ER signaling…
NATCO gets US FDA nod for Everolimus tablets
They are indicated in the treatment of breast cancer and a few other types of cancers
USFDA denies application from SPARC for cancer drug
The Office of New Drugs of the US FDA requested the conduct of a new Phase 3 study in metastatic breast cancer patients to support…
New potential breast cancer drug identified
Scientists, including an Indian-American researcher, have identified a molecule that can help treat breast cancer, giving hope to…
Alembic Pharma gets USFDA tentative nod for Palbociclib Capsules
It is indicated for breast cancer treatment
Global HER2-positive breast cancer market to face challenges from biosimilars through to 2025
The long-anticipated launch of oncology biosimilars in 2017 will be closely watched as drug makers expect to struggle with…
Cattle virus linked to breast cancer
Evidence of exposure to bovine leukemia virus was found in breast cancer cells, however researchers said that does not prove it…
Targeted therapies offer novel treatment modalities for breast cancer: Frost & Sullivan
The use of combination targeted therapies will improve progression-free disease as well as survival rates